Compare LXFR & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXFR | INNV |
|---|---|---|
| Founded | 1898 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.4M | 1.2B |
| IPO Year | 2002 | 2021 |
| Metric | LXFR | INNV |
|---|---|---|
| Price | $11.60 | $8.39 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 172.7K | ★ 326.2K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | 0.14 |
| Revenue | $384,600,000.00 | ★ $853,699,000.00 |
| Revenue This Year | N/A | $12.85 |
| Revenue Next Year | $5.01 | $8.88 |
| P/E Ratio | ★ $41.57 | $59.64 |
| Revenue Growth | N/A | ★ 11.76 |
| 52 Week Low | $9.41 | $2.60 |
| 52 Week High | $16.03 | $10.69 |
| Indicator | LXFR | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 23.84 | 49.53 |
| Support Level | $11.24 | $5.01 |
| Resistance Level | $12.33 | $9.18 |
| Average True Range (ATR) | 0.58 | 0.68 |
| MACD | -0.19 | -0.22 |
| Stochastic Oscillator | 3.52 | 7.09 |
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.